Stockreport

Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights [Yahoo! Finance]

Turnstone Biologics Corp.  (TSBX) 
PDF company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating lymphocyte (Selected TIL) therapy, to [Read more]